Today: 19 July 2026
Denison Mines stock drops 4% as uranium shares slide on fresh supply news — what to watch next

Denison Mines stock drops 4% as uranium shares slide on fresh supply news — what to watch next

NEW YORK, Feb 3, 2026, 09:32 EST — Regular session

  • Denison Mines shares fell early Tuesday, moving with a broader pullback in uranium-linked stocks.
  • Traders weighed softer uranium pricing and new supply signals.
  • Focus is on pending Canadian federal approvals that could unlock a construction start this quarter.

Shares of Denison Mines Corp (DNN) fell about 4.4% to $3.78 in early New York trading on Tuesday.

The move tracked losses in the uranium complex, with Cameco down about 2.6%, Uranium Energy off roughly 5.4% and the Global X Uranium ETF lower by about 3.2%.

Uranium equities have been trading on macro headlines, and Tuesday’s early tone followed fresh supply news out of Uzbekistan. The country said it lifted uranium production to 7,000 metric tons in 2025 and plans four new uranium mines for development in 2026, according to a Reuters report.

In pricing, UxC Uranium U3O8 futures on CME showed nearby contracts around the $99-per-pound area.

Denison is a Canada-based uranium explorer and developer focused on Saskatchewan’s Athabasca Basin, with its main growth project at Wheeler River. It holds a 95% interest in Wheeler River, which hosts the Phoenix and Gryphon deposits, according to Reuters data.

In a Jan. 2 update, Denison said its proposed Phoenix in-situ recovery (ISR) mine was ready to move to a final investment decision, pending final regulatory approvals. ISR is a well-based mining method that dissolves uranium underground and pumps it to the surface for processing. Chief Executive David Cates said the company “stands ready to make a final investment decision and commence construction” of the Phoenix ISR mine, and the company reiterated a mid-2028 first-production target if approvals arrive in the first quarter. Denison Mines Corp.

That timetable matters because Denison is still in the build-and-permit phase. For stocks like this, the commodity tape sets the daily mood, but permitting can change the story in a hurry.

There are risks either way. Federal decisions can slip, and any further easing in uranium prices would test sentiment, especially for developers without near-term cash flow from production.

Traders will be watching whether the broader uranium pullback keeps spreading, and whether sector moves stay tied to supply headlines rather than company specifics.

For Denison, the next clear marker is progress toward the remaining federal approvals it has said it needs before it can start construction on Phoenix in the first quarter of 2026.

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

Stock Market Today

  • BNY Mellon Trims Nasdaq Stake as Nasdaq Tops Earnings Estimates, Ups Dividend
    July 19, 2026, 3:41 AM EDT. Bank of New York Mellon Corp cut its stake in Nasdaq Inc (NASDAQ:NDAQ) by 3.3% to 2.19 million shares, valued at about $186 million in Q1. Nasdaq posted quarterly earnings of $0.96 per share, beating estimates by $0.03, on revenue of $2.14 billion, a 13.7% annual increase. The company lifted its quarterly dividend to $0.31 from $0.27, bringing the yield to 1.4%. Institutional investors own 72.47% of Nasdaq shares. Nasdaq shares opened at $91.64, close to its 50-day and 200-day moving averages of $87.32 and $88.75, respectively. Market capitalisation stands at $51.83 billion with a price-to-earnings ratio of 27.60. The results and dividend hike underscore strength following steady institutional activity.
British American Tobacco share price ticks up on fresh buyback notice as dividend, Feb 12 results near
Previous Story

British American Tobacco share price ticks up on fresh buyback notice as dividend, Feb 12 results near

Abbott (ABT) stock slips on FDA warning letter over FreeStyle Libre testing; dates to watch
Next Story

Abbott (ABT) stock slips on FDA warning letter over FreeStyle Libre testing; dates to watch

Go toTop